Jean-Marc Combette, CEO

Molecular Biologist, Jean-Marc Combette graduated in Business and Technology Management from the EM Lyon. He has nearly 20 years of experience in developing High-tech and Biotech products and taking care of their regulatory, technical and clinical aspects on both sides of the Atlantic.
Up to the inception of SOLID, he was President and CEO of a Swiss start-up company, which he successfully moved from a pure 'R' to a 'D' company. He was also Director of Development of a Private Investment Fund.
Previously, Jean-Marc Combette was Vice President (Drug Development) of a strategic consultancy to the biotech industry and has held managerial positions in international pharmaceutical companies. He has also been a Board Member of select pharmaceutical companies in Europe and the United States.


Catherine Deloche, COO

A Pharmacist with a PhD. in Clinical Pharmacology from the University of Geneva, Catherine Deloche is the former Vice President (Pre-clinical and Clinical Development) of a Swiss Biotech.
She has earlier held the position of Vice President (Scientific and Regulatory Affairs) of a Swiss-based strategic consultancy to the biotech industry. During her 10-year tenure, she acquired an extensive knowledge of clinical development of biotech products as well as a deep awareness of regulatory affairs, both in Europe and the US.